RXRA and hepatocellular carcinoma: ACR also suppresses HCC cell growth and inhibits the development of liver tumors by inhibiting the activation and expression of several types of growth factors and their corresponding receptor tyrosine kinases (RTKs), which lead to the inhibition of the Ras/MAPK activation and RXRα phosphorylation [8,9,14-17].